Your Source for Venture Capital and Private Equity Financings

VC-funded Company:

aTyr Pharma
3545 John Hopkins Court, Suite #250
San Diego, CA 92121
Phone: 858-731-8389

aTyr seeks to develop innovative therapeutics to address the unmet needs of patients by developing a novel class of biologic drugs. We have developed proprietary methods for discovering Physiocrines„¢, extracellular proteins that are derived from the tRNA synthetase family of enzymes, and which were predominantly overlooked by other genomic and secretome discovery efforts. aTyr™s proprietary discovery approach and expertise has enabled the exploration of this completely new class of biologic targets, and has allowed aTyr to establish a unique and comprehensive intellectual property portfolio across the Physiocrine family. We are currently developing a portfolio of Physiocrine therapeutic proteins, and focusing on indications in the areas of hematology, immune modulation, infection, and metabolism.

Key Contact
Name
John D. Mendlein
Title
CEO
Funding Events

Date
Amount
Type
Investors
Valuation
07/29/13 $10,000,000 Venture Debt Silicon Valley Bank
undisclosed
04/01/15 $76,000,000 Series E Deerfield Management Company, L.P.
EcoR1 Capital
Federated Kaufmann Funds
Rock Springs Capital
Sofinnova Ventures
Sphera Global Healthcare
T. Rowe Price Associates
undisclosed


Featured Reading